Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: Analysis of 141 cases

Leukemia Research

Volumn 21, Issue 7, 1997, Pages 603-607

  Raspadori, Donatella ^b   Lauria, Francesco ^a   Ventura, Maria Alessandra ^c   Rondelli, Damiano ^b   Visani, Giuseppe ^c   De Vivo, Antonio ^c   Tura, Sante ^c  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c NONE

Author keywords

AML; CD34; CR; MFI

Indexed keywords

CD34 ANTIGEN; FLUORESCEIN; MONOCLONAL ANTIBODY;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; IMMUNOFLUORESCENCE; INCIDENCE; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD34; BLAST CRISIS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MALE; MIDDLE AGED; PROGNOSIS;

EID: 0030968613     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00015-5     Document Type: Article

References (24)

1. + positive haemopoietic cells: biology and clinical applications. Blood Reviews, 1994, 8, 113.
2. + is encoded by a gene located on chromosome 1. Leukemia, 1989, 3, 773.
3. Civin, C. I., Strauss, L. C., Brovall, C., Fackler, M. J., Schwartz, J. F. and Sjaper, J. H., Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. Journal of Immunology, 1984, 133, 157.
4. + workshop antibodies. Tissue Antigens, 1993, 42, 374a.
5. Civin, C. L. and Gore, S. D., Antigenic analysis of hematopoiesis: a review. Journal of Hematotherapy, 1993, 2, 842.
6. Lanza, F., Moretti, S., Papa, S., Malavasi, F. and Castoldi, G., Report on the Fifth International Workshop on Human Leucocyte Differentiation Antigens, Boston, 3-7 November 1993. Haematologica, 1994, 79, 374.
7. Vaughan, W. P., Civin, C. I., Weisenburger, D. D., Karp, J. E., Graham, M. L., Sanger, W. G., Grierson, H. L., Joshi, S. S. and Burke, P. J., Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY 10). Leukemia, 1988, 2, 661.
8. Borowitz, M. J., Gockerman, J. P., Moore, J. O., Civin, C. I., Page, S. O., Robertosn, J. and Bigner, S. H., Clinico pathologic and cytogenetic features of CD34 (MY10)-positive acute nonlymphocytic leukemia. American Journal of Clinical Pathology, 1989, 91, 265.
9. Campos, L., Guyotat, D., Archimbaud, E., Devaux, Y., Treille, D., Larese, A., Maupas, J., Gentilhomme, O., Ehrsam, A. and Fiere, D., Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy. British Journal of Haematology, 1989, 72, 161.
10. Geller, R. B., Zahurak, M., Hurwitz, C. A., Burke, P. J., Karp, J. E., Piantadosi, S. and Civin, I., Prognostic importance of immunophenotyping in adults with acute myelocytic leukemia: the significance of the stem cell glycoprotein CD34 (My 10). British Journal of Haematology, 1990, 76, 340.
11. Myint, H. and Lucie, N. P., The prognostic significance of the CD34 antigen in acute myeloid leukaemia. Leukemia and Lymphoma, 1992, 7, 425.
12. Lanza, F., Rigolin, G. M., Moretti, S., Latorraca, A. and Castoldi, G., Prognostic value of immunophenotypic characteristics of blast cells in acute myeloid leukemia. Leukemia and Lymphoma, 1994, 13, 81.
13. Lamy, T., Goasguen, J. E., Mordelet, E., Grulois, I., Dauriac, C., Drenou, B., Chaperon, J., Fauchet, R. and Le Prise, P. Y., P-glycoprotein (p-170) and CD34 expression in adult acute myeloid leukemia (AML). Leukemia, 1994, 8, 1879.
14. + acute myeloid leukemia cells. Blood, 1993, 82, 3153.
15. Ciolli, S., Leoni, F., Caporale, R., Pascarella, A., Salti, F. and Rossi-Ferrini, P., CD34 expression fails to predict the outcome in adult acute myeloid leukemia. Haematologica, 1993, 78, 151.
16. Bennet, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A., Gralnick, H. R. and Sultan, C., Proposed revised criteria for the classification of acute myeloid leukemia. Annals of Internal Medicine, 1985, 103, 620.
17. Lauria, F., Raspadori, D., Ventura, M. A., Rondelli, D., Testoni, N., Tosi, P., Michieli, M., Damiani, D., Motta, M. R. and Tura, S., The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance. Stem Cells, 1995, 13, 428.
18. Kaplan, E. L. and Meier, P., Non parametric estimation for incomplete observations. Journal of the American Statistical Association, 1958, 53, 457.
19. Ball, E. D., Davis, R. B., Griffin, J. D., Mayer, R. J., Davey, F. R., Arthur, D. C., Wurster Hill, D., Noll, W., Elghetany, M. T. and Allen, S. L., Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood, 1991, 77, 2242.
20. Drexler, H. G., Thiel, E. and Ludwig, W. D., Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. Leukemia, 1993, 7, 489.
21. Lauria, F., Raspadori, D., Ventura, M. A., Rondelli, D. and Tura, S., CD7 expression does not affect the prognosis in acute myeloid leukemia. Blood, 1994, 83, 3097.
22. Porwit-MacDonald, A., Janossy, G., Ivory, K., Swirksky, D., Peters, R., Wheatley, K., Walker, H., Turker, A., Goldstone, A. H. and Burnett, A., Leukemia-associated changes identified by quantitative flow cytometry. IV CD34 overexpression in acute myelogenous leukemia with t(8;21). Blood, 1996, 87, 1162-1169.
23. Campos, L., Rouault, J. P., Sabido, O., Oriol, P., Roubi, N., Vasselan, C. and Archimbaud, E., High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood, 1993, 81, 3091-3096.
24. Lauria, F., Raspadori, D., Ventura, M. A., Rondelli, D., Pederzoli, A., Cimarelli, S. and Tura, S., High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and poor clinical outcome. Blood, Suppl. 1, 1994, 84, 378a.